A comparison of this case to previously published reports suggests that granulocyte colony-stimulating factor may be associated with improved prognosis in severe antithyroid drug-induced neutropenia, and that weight-based doses could be an appropriate strategy.
Keywords: Agranulocytosis; antithyroid; colony‐stimulating factor; methimazole; neutropenia.